Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.
Vaccines represent one of the greatest achievements of science and medicine in the fight against infectious diseases. Vaccination is one of the most cost-effective public health tools to prevent infectious diseases. Significant progress has been made in expanding the coverage of vaccines globally, resulting in the prevention of more than two million deaths annually. In 2010, nearly 200 countries endorsed a shared vision to extend the benefits of vaccines to every person by 2020, known as the Decade of Vaccine Initiative (DoV). Vaccine manufacturers in developing countries, as represented by the Developing Countries Vaccine Manufacturers Network (DCVMN), make a significant contribution to DoV by supplying quality vaccines at affordable prices to the people who need them most. About 70% of the global Expanded Program on Immunization (EPI) vaccine supplies are met by DCVMN. Besides EPI vaccine supplies, DCVMN is also targeting vaccines against rotavirus, Japanese encephalitis, pneumonia, human papillomavirus, meningitis and neglected tropical diseases. This article reviews the roles and contributions of DCVMN in making the vaccines accessible and affordable to all.
Serum Institute of India Limited, Pune, India.
S
S
Jadhav
M
M
Gautam
S
S
Gairola
D003140:Communicable Disease Control; D003906:Developing Countries / Q000191:economics; D006801:Humans; D017589:Immunization Programs / Q000639:trends*; D008458:Measles Vaccine / Q000191:economics* / Q000600:supply & distribution*; D011634:Public Health; D012411:Rubella Vaccine / Q000191:economics* / Q000600:supply & distribution*; D014611:Vaccination; D014944:World Health Organization
D008458:Measles Vaccine; D012411:Rubella Vaccine
Affordable healthcare; Developing Countries Vaccine Manufacturer Network; decade of vaccines; vaccines